It took months of delays and lawsuits... But on Tuesday, Skydance became one of the largest media conglomerates in the world.

Skydance is the name of the newly merged Paramount Skydance and Warner Bros. Discovery. Their new $111 billion deal is one of the most valuable mergers we've seen in the past decade. (The largest happened in 2020: the merger of United Technologies and Raytheon, which was completed in April for $135 billion.)

Despite these massive mergers, history shows us that companies are often stronger in separate pieces.

And many other conglomerates are splitting up... in a big way.

Our favorite way for a conglomerate to do so is by spinning off parts of its business.

When a company has a spinoff, it simply splits into two. If you hold shares of its stock worth, say, $100, you would end up with shares of two different stocks worth, say, $70 and $30.

But it's not the split that creates the magic. It's what happens afterward.

Spinoffs are proven to create value in a way that drives share prices up faster than the broad market.

Decades of studies have shown that the stock of the spun-off firm tends to outperform. One of the first studies came out in 1983 and looked at the period from 1963 to 1981. It found that spinoffs outperform by 2.84%. Later researchers have come to similar conclusions.

Perhaps Joel Greenblatt of Gotham Asset Management said it best in his excellent 1997 book, You Can Be a Stock Market Genius...

There are plenty of reasons why a company might choose to unload or otherwise separate itself from the fortunes of the business to be spun off. There is really only one reason to pay attention when they do: you can make a pile of money investing in spinoffs. The facts are overwhelming.

He quotes, among others, a Penn State study that showed spinoffs outperformed the S&P 500 Index by about 10% per year in their first three years of independence.

And even though investors discovered this idea in the 1980s, and in Greenblatt's bestseller, spinoffs continue to outperform. Take a look at Bloomberg's U.S. Spin-Off Index versus the S&P 500 since it started tracking such businesses in 2003...

When a profitable strategy remains so persistent over decades, it means something serious is happening. It's not just an investing trick. Spinoffs create real value.

And if you can figure out why, you can pick the best spinoffs.

My colleague Gabe Marshank believes a coming wave of corporate spinoffs could create one of the strongest investment environments he has seen for what he calls "ISOs," or investable spinoffs.

Gabe uses a five-part ISO Scorecard to identify the strongest opportunities within this group. Gabe says this process grew out of decades of professional experience and the strategy behind a single ISO investment that generated more than $100 million for his former firm.

To find out why 2027 is likely to deliver the biggest profit catalyst in 25 years for spinoffs, and how to position your portfolio for it, click here to hear Gabe's analysis.

Now, let's get to this week's Q&A... And as always, keep sending your comments, questions, and topic suggestions to feedback@healthandwealthbulletin.com. My team and I read every e-mail.

Vertigo or Lightheadedness?

Q: You did a very good job discussing vertigo, but as an otolaryngologist the most common problem I have seen was not true vertigo, but lightheadedness when moving from a more supine to upright position or medications given for vertigo as this elderly patient was given. It is something missed by many primary care doctors so I hope you have an opportunity to mention this somewhere. – J.S.

A: Thanks for writing in, J.S. This is a great point, and we wanted to make sure to share it with the rest of our readers.

Plenty of people experience short moments of vertigo, particularly when they sit up after lying down or stand up from a sitting position. We know that millions of Americans have orthostatic hypotension – where blood pressure can plummet upon standing. It's especially prevalent in people over 65.

The trick here is to move slowly. When you first get up in bed, give your body a minute a two to adjust to the new position before you fully get out of bed.

Side effects from plenty of medications include lightheadedness, such as statins, diabetes medication, antianxiety medication, and antidepressants (to name a few). Even common pain relievers can lead to that dizzy feeling.

Not eating or drinking enough can also lead to lightheadedness. Hypoglycemia (low blood sugar) hurts your brain's ability to function properly, which can trigger lightheadedness. Some medications make hypoglycemia more likely, especially if someone isn't eating enough (a common issue in the elderly). And if you're not getting enough fluid, your blood pressure drops, making it harder for your body to pump your blood. That means your brain might not get enough oxygen, causing dizziness.

Trouble with your inner ear – like an infection, excess fluid, or benign paroxysmal positional vertigo – commonly causes dizziness and lightheadedness.

If you think you have vertigo, take stock of when it occurs, review your medicines for side effects, and be honest about whether you're eating or drinking enough.

What We're Reading...

Here's to our health, wealth, and a great retirement,

Dr. David Eifrig and the Health & Wealth Bulletin Research Team
October 9, 2026

Recent Articles

View Full Archives
Subscribe to Health & Wealth Bulletin for FREE
Get the Health & Wealth Bulletin delivered straight to your inbox.
About Health & Wealth Bulletin

Here at Health & Wealth Bulletin, our manifesto is to provide a guide for living well – at a good price and on your own terms.

We've told folks the secret to life-changing income in retirement, the exit plan that every investor needs, and the key to beating the market. And our team has been on the leading edge of reporting new discoveries like immunotherapy, the dangers of BPA, the truth about cholesterol, and more.

You see, huge corporate interests and corrupt government institutions would rather people didn't know about many of these concepts... The more ignorant the people are, the better for the government and corporate interests. This keeps folks dependent... and the "nanny state" alive. That's why we spend our days uncovering the truth and sharing it with readers.

Health & Wealth Bulletin is your free guidebook to intriguing health and wealth ideas. It's all about living the best life possible.

About the Editor
Dr. David "Doc" Eifrig
Dr. David "Doc" Eifrig
Editor

Dr. David "Doc" Eifrig has one of the most remarkable resumes of anyone we know in the finance industry. After receiving his Bachelor of Arts degree from Carleton College in Minnesota, he went on to earn a Master of Business Administration degree

from Northwestern University's Kellogg School of Management. There, he graduated on the Dean's List with a double major in finance and international business.

Doc then went to work as an elite derivatives trader at the Goldman Sachs investment bank. He spent a decade on Wall Street with several major institutions, including Chase Manhattan Bank and Yamaichi Securities (then known as the "Goldman Sachs of Japan").

That's when Doc's career took an unconventional turn. Sick of the greed and hypocrisy on Wall Street, he quit his Senior Vice President position to become a doctor. He graduated from Columbia University's postbaccalaureate premedical program and eventually earned his Medical Doctor degree with clinical honors from the University of North Carolina at Chapel Hill. While in medical school, he was elected president of his class and admitted to the Order of the Golden Fleece – the highest honor awarded at the university.

Doc also completed a research fellowship in molecular genetics at Duke University and became a board-eligible eye surgeon. Along the way, he has been published in scientific journals and helped start a small biotechnology company, Mirus Bio, which was sold to Roche for $125 million in 2008.

However, frustrated by Big Medicine's many conflicts, Doc began to look for ways to talk directly with individuals. He wanted to use his background to show them how to take control of their health and wealth. In 2008, Doc joined Stansberry Research and launched his publication, Retirement Millionaire. He has gone on to launch Retirement Trader, which uses options to help people construct safe, reliable income streams. Doc's Income Intelligence seeks out income-producing investments to maximize returns. Prosperity Investor helps investors unlock massive potential gains in health care investing. Every Monday through Friday, Doc shares his views on the latest in the financial and health industries – and tips on how to improve your own life – in Health & Wealth Bulletin.

Doc has also authored five books with four-star ratings (or better) on Amazon. In his spare time, he has run three marathons and several triathlons. He owns and produces his own wine (Eifrig Cellars) in northern Sonoma County, California. Doc is also the CEO of MarketWise, Stansberry Research's parent company.

Back to Top